Trwa ładowanie...
dcske5l
dcske5l
espi

SOPHARMA AD - Current report 107 buy back 16102014 (107/2014)

SOPHARMA AD - Current report 107 buy back 16102014 (107/2014)
Share
dcske5l
POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 107 / 2014
Date of issue: 2014-10-16
Short name of the issuer
SOPHARMA AD
Subject
Current report 107 buy back 16102014
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
SOPHARMA AD hereby informs that from 9 October 2014 up to and including 15 October 2014 the Company bought 1 745 own shares representing 0.0013% of the share capital of the Company, to the total value of 6 955.83 BGN on the Bulgarian Stock Exchange, the average price per share was 3.99 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 102 858, representing 3.87% of the share capital of the Company.
Annexes
File Description
Current report 107 buy back 16102014.doc Current report 107 buy back 16102014

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2014-10-16 Ognian Donev Executive director

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY

dcske5l

Podziel się opinią

Share
dcske5l
dcske5l